Compounds > 4,4'-(2,2-bis((4-(aminoiminomethyl)-2-bromophenoxy)methyl)-1,3-propanediyl)bis(oxy))bis(3-bromobenzenecarboximidamide
Page last updated: 2024-09-04

4,4'-(2,2-bis((4-(aminoiminomethyl)-2-bromophenoxy)methyl)-1,3-propanediyl)bis(oxy))bis(3-bromobenzenecarboximidamide and Di Guglielmo Disease

4,4'-(2,2-bis((4-(aminoiminomethyl)-2-bromophenoxy)methyl)-1,3-propanediyl)bis(oxy))bis(3-bromobenzenecarboximidamide has been researched along with Di Guglielmo Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barbieri, R; Feriotto, G; Ferroni, R; Gambari, R; Guarneri, M; Nastruzzi, C1

Other Studies

1 other study(ies) available for 4,4'-(2,2-bis((4-(aminoiminomethyl)-2-bromophenoxy)methyl)-1,3-propanediyl)bis(oxy))bis(3-bromobenzenecarboximidamide and Di Guglielmo Disease

ArticleYear
Induction of murine erythroleukemia cell differentiation by proteinases is inhibited by aromatic poly-amidines.
    Cell biology international reports, 1989, Volume: 13, Issue:9

    Topics: Amidines; Animals; Benzamidines; Cell Differentiation; Cell Line; Erythrocytes; Erythropoiesis; Friend murine leukemia virus; Globins; Hemoglobins; Kallikreins; Leukemia, Erythroblastic, Acute; Mice; Protease Inhibitors; RNA, Messenger; Trypsin

1989